BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet.

Soverini S; Hochhaus A; Nicolini FE; Gruber F; Lange T; Saglio G; Pane F; Müller MC; Ernst T; Rosti G

doi:10.1182/blood-2010-12-326405

BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet.

Identifier:nobleid.org/w1/20260526/AD49CD89

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AD49CD89.svg?ark=w1%2F20260526%2FAD49CD89)](https://nobleid.org/work/w1/20260526/AD49CD89)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet.

Identifier:nobleid.org/w1/20260526/AD49CD89

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AD49CD89.svg?ark=w1%2F20260526%2FAD49CD89)](https://nobleid.org/work/w1/20260526/AD49CD89)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work